Search

Search Constraints

You searched for: Author/Creator Chelsky, Daniel

Search Results

1. Cdc42 and Rac1 activity is reduced in human pheochromocytoma and correlates with FARP1 and ARHGEF1 expression. Issue 4 (April 2016)

3. Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF. Issue 7 (24th April 2015)

4. Identification of NPTX2 as a prognostic biomarker of Alzheimer's disease through a longitudinal CSF proteomics study in ADNI subjects: Developing topics. (7th December 2020)

5. Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's disease. Issue 12 (13th May 2021)

7. Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification. Issue 8 (8th February 2021)